| Celularity to Present at H.C. Wainwright's 26th Annual Global Investment Conference | 09/05 16:05 | globenewswire.com |
| Celularity Appoints Richard J. Berman to its Board of Directors | 08/28 16:45 | globenewswire.com |
| Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing | 08/23 17:00 | globenewswire.com |
| Celularity Reports Full Year 2023 Combined Net Sales of $22.8 Million, a 26.7% Increase Over Full Year 2022, and Announces First Half 2024 Expected Combined Net Sales of $26.9 Million Representing 290% Growth Over First Half 2023 | 07/31 08:30 | globenewswire.com |
| Celularity Presents Data of The Effect of Its T-Cell Platform on Multiple Hematological And Solid Tumors at the American Society of Clinical Oncology (ASCO) Annual Meeting | 06/03 08:38 | globenewswire.com |
| Celularity Data Published in Journal for ImmunoTherapy of Cancer Reveals Benefits of Placental Circulating T Cells for CAR-T Therapy | 05/14 09:15 | globenewswire.com |
| Celularity Inc. to Host Investor and Analyst Research & Development Day | 04/22 08:00 | globenewswire.com |
| Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing | 04/19 17:30 | globenewswire.com |
| Celularity Abstract “Emerging Technologies for the Management and Protection of Tendon Injuries: Decellularized Placental Biomaterials” Accepted at ORS Tendon Conference 2024 | 04/18 16:30 | globenewswire.com |